VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IEXIDEX Corporation
$227.19$16.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksIEXCash Flow

IDEX Corporation (IEX) Cash Flow Statement

30Y historyFree accessUpdated daily

Cash conversion efficiency remains inconsistent, as demonstrated by the FCF margin contracting from 24.0% in 2024Q3 to 9.7% in 2026Q1, largely driven by significant working capital outflows.

IEX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations678.4M680.4M668.1M716.7M557.4M565.3M569.3M528.1M479.35M432.75M399.92M360.32M367.96M401.52M326.18M217.24M184.48M212.53M223.06M197.24M160.02M144.89M142.29M111.69M108.41M105.49M91.18M96.2M89.1M86.2M90.1M
Operating CF Margin %-19.68%20.44%21.89%17.52%20.45%24.21%21.17%19.3%18.92%18.93%17.83%17.13%19.84%16.69%11.82%12.19%15.98%14.98%14.52%13.86%13.89%15.33%14%14.61%14.51%12.95%14.69%13.92%15.61%16.01%
Operating CF Growth %39.64%1.84%-6.78%28.58%-1.4%-0.7%7.8%10.17%10.77%8.21%10.99%-2.08%-8.36%23.1%50.15%17.76%-13.2%-4.72%13.09%23.26%10.44%1.82%27.41%3.03%2.76%15.7%-5.22%7.97%3.36%-4.33%63.52%
Net Income507.7M482.5M504.6M595.6M586.7M449.3M377.8M425.5M410.57M337.26M271.11M282.81M279.39M255.22M37.63M193.86M157.1M113.39M127.03M155.15M146.67M109.8M86.41M62.35M54.11M32.71M63.45M54.4M64.6M58.7M50.2M
Depreciation & Amortization210.3M206.5M175.6M152.1M119.7M103M83.5M76.9M77.54M84.22M86.89M78.12M76.91M79.33M78.31M72.39M58.11M56.35M48.6M38.5M30.41M26.94M31.53M30.05M30.11M44.3M36.7M34.8M33.5M24.9M21.2M
Stock-Based Compensation25.9M27.3M25.8M21.8M21.6M20.4M14.8M22.1M24.75M24.41M20.33M20.05M20.72M16.99M13.1M12.08M17.36M15.71M15.01M000000000000
Deferred Taxes11.3M12.8M-19.4M-14.7M-18.5M-6.1M8.2M6.6M-4.34M-33.74M-17.31M-339K-8.59M-3.16M-37.23M-3.58M-7.34M1.08M-10.82M2.45M1.31M4.32M10.78M10.49M9.59M-152K1.08M3.7M3.4M6.3M4.4M
Other Non-Cash Items-50.3M700K-1.5M-70.9M-16.7M16.7M9.9M24.8M-10.55M23.43M33.25M-11.48M2.38M4.04M201.38M-40.05M-28.33M7.39M33.13M6.66M-9.58M3.58M0-5.42M629K-6.04M-3.96M200K-5.9M400K6.7M
Working Capital Changes-25.9M-49.4M-17M32.8M-135.4M-18M75.1M-27.8M-18.63M-2.81M5.65M-8.84M-2.84M49.09M32.99M-17.45M-12.43M18.61M10.11M-5.51M-8.8M245K13.58M14.21M13.97M34.68M-6.09M3.1M-6.5M-4.1M7.6M
Change in Receivables-44.1M-41.2M-16.9M20.5M-71.7M-49.4M20.9M22.3M-23.42M-15.8M302K8.83M-11.11M6.2M12.75M-16.49M-22.16M26.07M19.67M-8.71M-14.42M-18.22M-5.95M6.87M1.01M24.01M-109K-900K7.4M3.6M-6.6M
Change in Inventory-24.8M-34.2M17.6M66.2M-72.4M-46.1M36.5M-3.32M-23.03M760K32.75M4.56M-7.82M9.09M23.8M-607K-26.65M23.15M-9.66M-3.5M-7.2M-3.93M-9.28M4.62M6.25M22.23M-2.41M4.8M1.2M7.7M19.3M
Change in Payables6.2M15.2M8.9M-25.3M17.6M22.9M2.7M-9.12M-1.22M12.56M73K-2.83M-2.47M15.46M-1.38M-8.64M21.43M-16.31M-724K000000000000
Cash from Investing-148M-137.6M-1.01B-283.8M-917.2M-698.1M-172.6M-137M-81.43M-54.75M-509.2M-210.49M-72.26M-68.16M-105.27M-469.54M-122.31M-19.62M-280.66M-248.6M-348.18M-24.1M-191.55M-38.84M-90.33M-152.13M-53.7M-66.8M-99.2M-63.3M-144.2M
Capital Expenditures-67M-63.6M-65.1M-89.9M-68M-72.7M-51.6M-50.9M-56.09M-43.86M-38.24M-43.78M-48M-31.54M-35.81M-35.17M-31.74M-25.06M-27.84M-24.5M-21.2M-22.53M-21.1M-20.32M-19.34M-21.64M-20.74M-66.8M-138.9M-13.6M-144.2M
CapEx % of Revenue1.9%1.84%1.99%2.75%2.14%2.63%2.19%2.04%2.26%1.92%1.81%2.17%2.23%1.56%1.83%1.91%2.1%1.88%1.87%1.8%1.84%2.16%2.27%2.55%2.61%2.98%2.94%10.2%21.7%2.46%25.63%
Acquisitions-80.4M-76.2M-939.4M-193.2M-896.2M-577.4M-123.1M-87.2M-20.2M-16.37M-470.94M-167.34M-25.44M-36.85M-68.93M-443.63M-91.29M0-392.82M-86.21M-359.84M-1.19M-170.98M-21.95M-74.93M-132.29M-34.51M0000
Investments-------------------------------
Other Investing-600K2.2M-6.5M3.5M7.3M-2.8M2.1M1.1M-5.14M5.48M-20K621K1.18M223K-529K9.27M720K5.44M140M-137.89M32.87M-376K527K3.44M3.93M1.81M1.55M039.7M-49.7M0
Cash from Financing-568.1M-632.6M465.9M-344.7M-37.8M-9.5M-42.6M-227.6M-290.01M-277.42M46.55M-295.53M-184.07M-219.04M-136.49M253.41M95.52M-184.98M22.68M71.74M184.77M-50.85M47.98M-71.25M-16.1M43.19M-31.96M-29.1M1.1M-15.9M53.2M
Debt Issued (Net)-128.7M-170.9M656.9M-150M275.4M149.3M198.7M-50.1M-11.28M-167.62M181.4M-8.02M103.06M-16.38M-29.35M279.23M125.11M-155.49M100.5M89.66M193.52M-61.78M47.7M-63.43M-54.51M50.97M-17.82M-14.7M11.8M-2.2M64.6M
Equity Issued (Net)-274.1M-248.3M16.7M-2.7M-134M13.6M-110.3M-54.7M-173.93M-29.07M-57.27M-210.82M-219.89M-167.5M-89.56M000-50M14M17.21M37.5M22.85M13.18M56.59M9M2.82M2.8M3.3M1M0
Dividends Paid-213M-212.6M-205.3M-190.7M-177.4M-161.1M-151.8M-147.2M-127.48M-111.17M-102.65M-96.17M-85.73M-72.91M-64.09M-54.61M-46.33M-38.64M-39.4M-37.27M-30.39M-24.69M-21.41M-18.28M-17.72M-17.06M-16.78M-16.5M-15.8M-14M-12.3M
Share Repurchases-274.1M-247.8M0-24.2M-148.1M0-110.3M-54.7M-173.93M-29.07M-57.27M-210.82M-219.89M-167.5M-89.56M000-50M0000000-46K-100K000
Other Financing47.7M-800K-2.4M-1.3M-1.8M-11.3M20.8M24.4M22.68M30.44M25.07M19.48M18.48M37.74M46.51M28.79M16.75M9.14M11.57M5.35M4.43M-1.89M-1.15M-2.71M-458K284K-167K-700K1.8M-700K900K
Net Change in Cash-20.4M-53M104.6M104.1M-425.2M-170.5M393.3M166.2M90.46M139.99M-92.05M-181.12M69.51M120.77M88.61M-4.88M161.61M12.17M-41.4M24.81M653K70.02M-1.28M1.6M1.98M-3.44M5.52M200K-2.3M-16.9M53.2M
Free Cash Flow611.4M616.8M603M626.8M489.4M492.6M517.7M477.2M419.26M388.89M361.68M316.55M319.96M369.99M290.37M182.07M152.74M187.47M195.22M172.74M138.82M122.36M121.2M91.37M89.07M83.85M70.44M29.4M-49.8M72.6M-54.1M
FCF Margin %17.32%17.84%18.45%19.15%15.38%17.82%22.01%19.13%16.88%17%17.12%15.67%14.9%18.28%14.86%9.9%10.09%14.1%13.11%12.71%12.02%11.73%13.06%11.45%12%11.54%10%4.49%-7.78%13.15%-9.62%
FCF Growth %9.61%2.29%-3.8%28.08%-0.65%-4.85%8.49%13.82%7.81%7.53%14.26%-1.07%-13.52%27.42%59.49%19.2%-18.53%-3.97%13.02%24.44%13.46%0.96%32.65%2.58%6.22%19.04%139.6%159.04%-168.59%234.2%-228.5%
FCF per Share8.228.197.948.266.446.456.786.245.415.034.714.063.964.493.472.181.862.322.372.101.711.551.571.221.221.201.020.43-0.741.07-0.81
FCF Conversion (FCF/Net Income)1.20x1.41x1.32x1.20x0.95x1.26x1.51x1.24x1.17x1.28x1.48x1.27x1.32x1.57x8.67x1.12x1.17x1.87x1.70x1.27x1.09x1.32x1.65x1.79x2.00x3.23x1.44x1.77x1.38x1.47x1.79x
Interest Paid36.5M047.4M50.8M37.1M36M35.2M36.7M36.33M36.82M37.07M33.5M32.56M33.43M32.64M27.75M16.78M17.31M20.14M000000000000
Taxes Paid83.5M0171.4M199.5M175.6M118.2M87.2M109M90.73M104.85M109.4M112.61M122.3M73.66M87.6M66.09M73.87M50.8M72.07M000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowStable
Top Statement Risk

Bioprocessing demand volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality and Cash Conversion

According to recent quarterly filings, IDEX's OCF/NI ratio has fluctuated significantly, ranging from a low of 0.86 in 2026Q1 to a high of 1.85 in 2023Q4, indicating that GAAP net income frequently diverges from the company's actual cash-generating capacity due to non-cash charges and accruals.

The volatility in the OCF/NI ratio suggests that investors should be cautious when relying solely on net income as a proxy for performance. The periodic reliance on non-cash adjustments to bridge the gap between accounting profit and cash flow warrants further investigation into the sustainability of these accruals.

Free Cash Flow Margin Variability

As reported in financial statements, IDEX's FCF margins have shown notable inconsistency, peaking at 24.0% in 2024Q3 before contracting to 9.7% in 2026Q1, which reflects the company's sensitivity to working capital swings and the lumpy nature of its project-based revenue streams across its three primary segments.

This margin compression appears to be driven by periodic working capital outflows rather than a structural decline in profitability. Analysts should monitor whether these FCF fluctuations represent a permanent shift in the business model or merely temporary timing differences in project execution and inventory management.

Working Capital Efficiency and Volatility

Based on reported figures, IDEX experienced a significant working capital outflow of $89.9 million in 2026Q1, contrasting sharply with the $82.5 million inflow seen in 2025Q3, highlighting the inherent difficulty in managing cash cycles across diverse industrial and life science end-markets with varying payment terms.

The erratic nature of these working capital changes suggests that the company's cash flow is highly susceptible to inventory build-ups or delayed collections. This volatility may indicate that the 80/20 operational model is facing challenges in maintaining consistent cash conversion efficiency during periods of shifting demand.

Disciplined Capital Allocation Strategy

As evidenced by recent financial disclosures, IDEX continues to prioritize shareholder returns through consistent dividend payments and opportunistic buybacks, with $76.3 million deployed toward share repurchases in 2026Q1, even as the company maintains a fortress balance sheet with minimal leverage to support future bolt-on acquisition activity.

The company's ability to fund both dividends and buybacks while simultaneously pursuing acquisitions suggests a robust capital allocation framework. However, investors should monitor whether the increasing scale of the business makes finding high-return acquisition targets more difficult, potentially leading to less efficient capital deployment in the future.

IEX — Frequently Asked Questions

Quick answers to the most common questions about buying IEX stock.

How much cash does IDEX Corporation (IEX) generate from operations?

IDEX Corporation (IEX) generated $680.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is IDEX Corporation's free cash flow?

IDEX Corporation (IEX) generated $616.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is IDEX Corporation's capital expenditure (CapEx)?

IDEX Corporation (IEX) spent $63.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does IDEX Corporation distribute cash to shareholders?

In 2025, IDEX Corporation (IEX) returned $212.6M to shareholders via cash dividends and spent $247.8M on share repurchases. This shows the company's commitment to returning capital to its equity investors.